You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.
In early May, we highlighted how Aphria had been proactive in addressing a balance sheet issue by buying back some of its convertible debt at a big discount, issuing shares to the debt holders. We suggested that Aphria’s actions could serve as a model for Canadian and American operators that took on too much debt. Earlier this month, Supreme Cannabis was able to restructure its C$100 million convertible debt, and VIVO Cannabis did so as well last week on a smaller amount.
Whether it’s through convertible debt that is underwater or straight debt, many companies are burdened by too much debt, and the stock prices reflect the risk of the company going into bankruptcy. We have already seen several bankruptcies in both Canada and the United States among publicly traded companies, and there have been some restructurings, like the one iAnthus shareholders just approved, that fall short of bankruptcy but are effectively the same thing, as equity holders are pretty much wiped out.
We think investors should be paying close attention to these transactions, as a debt-for-equity swap has the potential to create gains for equity investors. First, if the restructuring of the balance sheet leaves the company with plenty of runway, equity investors will be more confident given the lower probability of bankruptcy. Second, and perhaps more important, the actual process can have a very negative short-term impact. Recall the awkward transaction done by Aurora Cannabis in November, which crushed its stock. More recently, many of the shares issued by Supreme apparently hit the market, pushing the stock to a new multi-year low. The Canadian chart below illustrates the high volume (9.0 million shares), and there were also 9.5 million shares traded in the U.S):
The negative headline of dilution due to the shares being issued and the technical impact of some or all of those shares hitting the market happen ahead of the financial statements that reflect the better balance sheet due to the elimination of debt. In the case of Supreme, the company issued 116.6 million shares (50% free-trading, 50% locked up for 4 months), which boosted the share count by 30%. Investors won’t see the substantial debt reduction on the balance sheet until the company reports in November, but the tangible equity will go up by about 50%. By our calculations, the stock is trading at about 40% of the adjusted tangible book value.
It will be interesting to see if the short-term pain inflicted on the stock of Supreme Cannabis by the transaction will yield upside to investors. In general, with the risk of bankruptcy reduced, investors should be more inclined to invest if this is what was weighing down the stock. While Aphria’s transaction was smaller relative to the entire capital structure and the company wasn’t in as precarious of a position as Supreme appeared to be, we note that it has performed far better than its peers since it announced its transaction on May 8th. There are many factors at play most likely, but we believe that the balance sheet improvement was certainly one:
Many other cannabis companies are struggling with near-term debt maturities, and we continue to expect debt for equity swaps to help address the challenges for some of them. Investors may be able to take advantage of stocks that have been overly discounted for worst-case scenarios and that then suffer in the short-term from selling of the shares issued to debt holders.
The premier gathering of cannabis entrepreneurs and investors in North America returns virtually on October 15. Benzinga’s virtual Cannabis Capital Conference offers participants all the benefits of an immersive and robust in-person conference from any remote location. Featuring an interactive forum of live and On-Demand presentations from top CEOs, investors and leaders in the cannabis industry.
If your company is interested in presenting please contact us at firstname.lastname@example.org for consideration.
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:
- Aurora Cannabis Q4 Revenue Decreases 5% Sequentially to $72.1 Million
- Exclusive: Cannabis Tech Company Dutchie Positions to Extend 25% Market Share in Cannabis Ecommerce
- Exclusive: CBD Company Kadenwood Brands Bets on Vertical Integration for Long-Term Success
- KushCo Expects Fiscal Q4 Revenue to Increase 14-17% Sequentially
- WeedMD Taps Labor Union Pension Fund for $30 Million Credit Facility at 15% Interest Rate
To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.
Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013. Gain immediate access to real-time and in-depth information and market intelligence about the publicly traded cannabis sector, including daily videos, weekly chats, model portfolios, a community forum and much more.
Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.
View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than US$10M per quarter.
Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.
Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.
Alan & Joel